Castle Biosciences, Inc. · NASDAQ:CSTL

Juvenal Tobin W sold 3,288 Castle Biosciences, Inc. shares (Form 4)

Traded Oct 12, 2026 · Filed Oct 14, 2026

On Oct 12, 2026, Juvenal Tobin W (Chief Commercial Officer) sold 3,288 Castle Biosciences, Inc. shares at US$33.64 for US$111K under a trading plan, leaving 48,719 shares. Filed Oct 14, 2026 (Form 4).

Sold
3,288 shares
Price
US$33.64
Value
US$111K
Holding after
48,719 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Commercial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 12, 2026Common StockSale3,288US$33.6448,719Direct

Source

View original at SEC

Related